National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PEG-interleukin-2
A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity and the production of interferon-gamma (IFN-gamma), and enhances T cell-mediated cytotoxicity. Pegylation of IL-2 protects the cytokine from degradation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:polyethylene glycol-modified recombinant interleukin-2
Abbreviation:PEG-IL-2



Previous:PDGFR inhibitor CP-868596, Pedi-Vit-A, PedvaxHIB, PEG-interferon alfa-2a, PEG-interferon alfa-2b
Next:PEG-Intron, pegaspargase, PEGASYS, pegfilgrastim, pegylated anti-GFR antibody fragment

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov